Table 2.
Laboratory parameters at admission
| Parameter | Missing data | Entire cohort | Survivors | Non-survivors | P-value |
|---|---|---|---|---|---|
| (N = 586) | (N = 498) | (N = 88) | |||
| N | Median (IQR) | Median (IQR) | Median (IQR) | ||
| Haemoglobin (g/dL) | 173 | 13.6 | 13.7 | 12.8 | 0.002 |
| (12.3–14.8) | (12.5–14.8) | (11.2–14.2) | |||
| Red blood cell count (×1012/L) | 139 | 4.54 | 4.57 | 4.21 | 0.001 |
| (4.09–4.96) | (4.14–4.99) | (3.63–4.77) | |||
| Platelet count (×109/L) | 159 | 186 | 192 | 171 | 0.045 |
| (150–247) | (153–251) | (135–222) | |||
| Leucocyte count (×109/L) | 159 | 5.7 | 5.5 | 6.5 | 0.003 |
| (4.3–7.9) | (4.2–7.7) | (4.6–10.5) | |||
| Lymphocyte count (×109/L) | 144 | 1.15 | 1.21 | 0.87 | 0.001 |
| (0.74–9.25) | (0.78–11.55) | (0.65–3.31) | |||
| C-reactive protein (mg/L) | 162 | 50.65 | 48.2 | 84.0 | <0.001 |
| (20.18–95.93) | (16.8–89.4) | (34.0–169.5) | |||
| D-dimer (mg/L) | 366 | 0.79 | 0.70 | 1.55 | <0.001 |
| (0.52–1.56) | (0.48–1.29) | (0.89–2.04) | |||
| Prothrombin time (%) | 229 | 101 | 103 | 93 | <0.001 |
| (88–110) | (90–111) | (68–100) | |||
| International normalized ratio | 274 | 1.00 | 1.00 | 1.06 | <0.001 |
| (1.00–1.07) | (1.00–1.05) | (1.00–1.10) | |||
| Activated partial thromboplastin time (s) | 256 | 30.7 | 30.3 | 33.0 | 0.012 |
| (27.5–34.0) | (27.4–33.8) | (28.8–39.2) |
For detailed information on missing data, refer to Supplementary material online, Table S3. Bold values indicate statistically significant results.
BMI, body mass index; COVID-19, coronavirus disease 2019; ICU, intensive care unit; IQR, interquartile range; mmHg, millimetre mercury; SpO2, peripheral capillary oxygen saturation.